company background image
MDC

Medlab Clinical ASX:MDC Stock Report

Last Price

AU$7.65

Market Cap

AU$17.5m

7D

-4.4%

1Y

-64.8%

Updated

05 Dec, 2022

Data

Company Financials +
MDC fundamental analysis
Snowflake Score
Valuation3/6
Future Growth2/6
Past Performance0/6
Financial Health4/6
Dividends0/6

MDC Stock Overview

Medlab Clinical Limited, a biotechnology company, researches, develops, and pre-commercializes pharmaceutical and nutraceutical products in Australia.

Medlab Clinical Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Medlab Clinical
Historical stock prices
Current Share PriceAU$7.65
52 Week HighAU$23.25
52 Week LowAU$6.45
Beta1.51
1 Month Change-24.26%
3 Month Change-41.15%
1 Year Change-64.83%
3 Year Change-84.78%
5 Year Change-93.20%
Change since IPO-74.50%

Recent News & Updates

Recent updates

Shareholders May Be More Conservative With Medlab Clinical Limited's (ASX:MDC) CEO Compensation For Now

Oct 06
Shareholders May Be More Conservative With Medlab Clinical Limited's (ASX:MDC) CEO Compensation For Now

Is Medlab Clinical (ASX:MDC) In A Good Position To Invest In Growth?

Oct 05
Is Medlab Clinical (ASX:MDC) In A Good Position To Invest In Growth?

What We Learned About Medlab Clinical's (ASX:MDC) CEO Pay

Feb 21
What We Learned About Medlab Clinical's (ASX:MDC) CEO Pay

Medlab Clinical (ASX:MDC) Share Prices Have Dropped 69% In The Last Three Years

Dec 30
Medlab Clinical (ASX:MDC) Share Prices Have Dropped 69% In The Last Three Years

Medlab Clinical Limited (ASX:MDC) Is Expected To Breakeven In The Near Future

Nov 22
Medlab Clinical Limited (ASX:MDC) Is Expected To Breakeven In The Near Future

Shareholder Returns

MDCAU BiotechsAU Market
7D-4.4%0.9%0.6%
1Y-64.8%-1.6%-1.8%

Return vs Industry: MDC underperformed the Australian Biotechs industry which returned -1.6% over the past year.

Return vs Market: MDC underperformed the Australian Market which returned -1.8% over the past year.

Price Volatility

Is MDC's price volatile compared to industry and market?
MDC volatility
MDC Average Weekly Movement7.3%
Biotechs Industry Average Movement8.8%
Market Average Movement9.0%
10% most volatile stocks in AU Market15.9%
10% least volatile stocks in AU Market4.1%

Stable Share Price: MDC is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: MDC's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2012n/aSean Hallhttps://www.medlab.co

Medlab Clinical Limited, a biotechnology company, researches, develops, and pre-commercializes pharmaceutical and nutraceutical products in Australia. Its drug candidate includes NanaBis, a buccal spray from cannabis oil extract for oncology and pain management; and NanoCBD, a buccal spray from hemp oil extract for mental health. The company also develops NanoCelle, a patented sub-micron drug delivery platform that allows passive diffusion of active pharmaceutical ingredients directly into the bloodstream through oral-buccal, sublingual, intranasal, and transdermal or topical delivery.

Medlab Clinical Limited Fundamentals Summary

How do Medlab Clinical's earnings and revenue compare to its market cap?
MDC fundamental statistics
Market CapAU$17.47m
Earnings (TTM)-AU$8.32m
Revenue (TTM)AU$1.54m

11.4x

P/S Ratio

-2.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
MDC income statement (TTM)
RevenueAU$1.54m
Cost of RevenueAU$336.29k
Gross ProfitAU$1.20m
Other ExpensesAU$9.52m
Earnings-AU$8.32m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-3.64
Gross Margin78.11%
Net Profit Margin-541.67%
Debt/Equity Ratio0%

How did MDC perform over the long term?

See historical performance and comparison